Thu, September 21, 2023
Wed, September 20, 2023
Tue, September 19, 2023
Mon, September 18, 2023
Fri, September 15, 2023
Thu, September 14, 2023
Wed, September 13, 2023

Brian Abrahams Upgraded (BCRX) to Buy and Increased Target to $10 on, Sep 18th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-10-on-sep-18th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Upgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Buy and Increased Target from $9 to $10 on, Sep 18th, 2023.

Brian has made no other calls on BCRX in the last 4 months.



There are 4 other peers that have a rating on BCRX. Out of the 4 peers that are also analyzing BCRX, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Friday, August 4th, 2023
  • Maury Raycroft of "Jefferies" Upgraded from Hold to Strong Buy and Held Target at $11 on, Friday, August 4th, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy with Decreased Target to $12 on, Thursday, August 3rd, 2023
  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $10 on, Thursday, July 13th, 2023

Publication Contributing Sources